Literature DB >> 1530653

A fluorescence-microscopic and flow-cytometric study of HeLa cells with an experimentally induced respiratory deficiency.

P Skowronek1, O Haferkamp, G Rödel.   

Abstract

HeLa cells, cultured over a long period in a medium containing low doses of ethidiumbromide, were used as a model system for flow-cytometric detection of human cells with impaired mitochondrial respiratory function. Based on laserscan and flowcytometric analysis after rhodamine 123 staining, the mitochondrial membrane potential of respiratory deficient cells seems unchanged as compared to control cells. Maintenance of this membrane potential in respiration-impaired cells requires glycolytic ATP generation, as transient inhibition of glycolysis by sodium fluoride affects rhodamine 123 accumulation in ethidiumbromide-treated cells, but not in control cells. We present a protocol which allows the detection and separation of respiratory deficient cells by flow cytometry.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530653     DOI: 10.1016/0006-291x(92)91295-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Cytochrome c oxidase deficiency in human posterior cricoarytenoid muscle.

Authors:  Cari M Tellis; Clark Rosen; John M Close; Michael Horton; J Scott Yaruss; Katherine Verdolini-Abbott; James J Sciote
Journal:  J Voice       Date:  2010-08-04       Impact factor: 2.009

2.  ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis.

Authors:  C Stefanelli; F Bonavita; I Stanic'; G Farruggia; E Falcieri; I Robuffo; C Pignatti; C Muscari; C Rossoni; C Guarnieri; C M Caldarera
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

3.  Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40.

Authors:  J L Vayssiere; P X Petit; Y Risler; B Mignotte
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

4.  Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl.

Authors:  J S Wadia; R M Chalmers-Redman; W J Ju; G W Carlile; J L Phillips; A D Fraser; W G Tatton
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

5.  Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie; Eric Gobin; Pascale Marcorelles; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2006-07-22       Impact factor: 4.130

6.  Antisense-mediated decrease in DNA ligase III expression results in reduced mitochondrial DNA integrity.

Authors:  U Lakshmipathy; C Campbell
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

7.  Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis.

Authors:  P X Petit; H Lecoeur; E Zorn; C Dauguet; B Mignotte; M L Gougeon
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

8.  Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization.

Authors:  M Deshmukh; K Kuida; E M Johnson
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

9.  Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

Authors:  N Zamzami; P Marchetti; M Castedo; C Zanin; J L Vayssière; P X Petit; G Kroemer
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

10.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Authors:  N Zamzami; P Marchetti; M Castedo; D Decaudin; A Macho; T Hirsch; S A Susin; P X Petit; B Mignotte; G Kroemer
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.